BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8394992)

  • 1. Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system.
    Aharony D; Little J; Powell S; Hopkins B; Bundell KR; McPheat WL; Gordon RD; Hassall G; Hockney R; Griffin R
    Mol Pharmacol; 1993 Aug; 44(2):356-63. PubMed ID: 8394992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
    Aharony D; Little J; Thomas C; Powell S; Berry D; Graham A
    Mol Pharmacol; 1994 Jan; 45(1):9-19. PubMed ID: 8302285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of neurokinin A receptor cDNAs from guinea-pig lung and rabbit pulmonary artery.
    Aharony D; Little J; Thomas C; Powell S; Downey-Jones M; Graham A
    J Recept Res; 1994 Dec; 14(6-8):399-421. PubMed ID: 7877137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic characterization of the novel ligand [4,5-3H-Leu9]neurokinin-A binding to NK-2 receptors on hamster urinary bladder membranes.
    Aharony D; Conner GE; Woodhouse DP
    Neuropeptides; 1992 Oct; 23(2):121-30. PubMed ID: 1333574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of rat NK-2 (neurokinin A) receptor in E. coli.
    Grisshammer R; Little J; Aharony D
    Recept Channels; 1994; 2(4):295-302. PubMed ID: 7719707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the novel ligand [4,5-3H-Leu10]substance P to high-affinity NK-1 receptors on guinea pig lung membranes: modulation by GTP analogs and sulfhydryl modifying agents.
    Aharony D; Catanese CA; Woodhouse DP
    J Pharmacol Exp Ther; 1991 Oct; 259(1):146-55. PubMed ID: 1717678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon.
    Warner FJ; Comis A; Miller RC; Burcher E
    Br J Pharmacol; 1999 Jul; 127(5):1105-10. PubMed ID: 10455255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of a novel, selective radioligand, [125I][Lys5,Tyr(I2)7,MeLeu9,Nle10]neurokinin A-(4-10), for the tachykinin NK2 receptor in rat fundus.
    Burcher E; Badgery-Parker T; Zeng XP; Lavielle S
    Eur J Pharmacol; 1993 Mar; 233(2-3):201-7. PubMed ID: 8385622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888.
    Miyayasu K; Mak JC; Nishikawa M; Barnes PJ
    Mol Pharmacol; 1993 Sep; 44(3):539-44. PubMed ID: 7690449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
    Goso C; Astolfi M; Parlani M; Manzini S
    Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of NK-1 receptors in guinea pig and rat brain membranes with NK-1 peptides and a non-peptide antagonist.
    Tousignant C; Chrétien L; Guillemette G; Regoli D
    Brain Res; 1992 Nov; 596(1-2):243-50. PubMed ID: 1281744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
    Blaney FE; Raveglia LF; Artico M; Cavagnera S; Dartois C; Farina C; Grugni M; Gagliardi S; Luttmann MA; Martinelli M; Nadler GM; Parini C; Petrillo P; Sarau HM; Scheideler MA; Hay DW; Giardina GA
    J Med Chem; 2001 May; 44(11):1675-89. PubMed ID: 11356103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).
    Giardina GA; Raveglia LF; Grugni M; Sarau HM; Farina C; Medhurst AD; Graziani D; Schmidt DB; Rigolio R; Luttmann M; Cavagnera S; Foley JJ; Vecchietti V; Hay DW
    J Med Chem; 1999 Mar; 42(6):1053-65. PubMed ID: 10090788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.
    Hay DW; Giardina GA; Griswold DE; Underwood DC; Kotzer CJ; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Martin LD; Kilian D; Legos JJ; Barone FC; Luttmann MA; Grugni M; Raveglia LF; Sarau HM
    J Pharmacol Exp Ther; 2002 Jan; 300(1):314-23. PubMed ID: 11752131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachykinin NK2 receptors: characterization in the rat small intestine by the use of a peptide agonist and a nonpeptide antagonist as radioligands.
    Renzetti AR; Criscuoli M; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):139-44. PubMed ID: 9228201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor.
    Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Ferrer C; Giolitti A; Guelfi M; Rotondaro L; Warner FJ; Maggi CA
    J Pharmacol Exp Ther; 1999 Aug; 290(2):487-95. PubMed ID: 10411554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of mucin secretion from CHO-K1-hNK(1)R cells.
    Caccese R; Graham A; Bialecki R
    Neuropeptides; 1999 Jun; 33(3):239-43. PubMed ID: 10657498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and functional potency of neurokinin A analogues in the rat fundus: A structure-activity study.
    Matuszek MA; Comis A; Burcher E
    Pharmacology; 1999 May; 58(5):227-35. PubMed ID: 10087463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle.
    Bergström L; Beaujouan JC; Torrens Y; Saffroy M; Glowinski J; Lavielle S; Chassaing G; Marquet A; D'Orleans-Juste P; Dion S
    Mol Pharmacol; 1987 Dec; 32(6):764-71. PubMed ID: 2826990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.